SLS

SLS Earnings Preview

SELLAS Life Sciences Group, Inc. · Healthcare · $903M

14d until earnings

SLS Earnings

Tuesday, May 12 2026
EPS Estimate
$-0.06
$-0.08 – $-0.04
Current Price
$4.46

Data Signal Summary

2 bullish
1 bearish
Insider buying cluster Put/call 0.0 (bullish skew) Price downtrend

Key Context

Insider Activity
buying
Price Trend
downtrend
From 52w High
-14.6%
Est. Revisions (30d)
+0.0% 1up/0dn
Analyst Target (mean)
$10 $10–$10 +124%
Options P/C Ratio
0.03
Est. Dispersion
67% 2 analysts
Insider Cluster
strong buy
Fund Convergence
moderate Citadel, Two Sigma

Recent Activity

insider trades 19 transactions
Award · BURNS JOHN THOMAS (Chief Financial Officer) ·300,000 shares
Award · KALIN KATHERINE BACH (Director) ·50,000 shares
Award · VARIAN JOHN W (Director) ·50,000 shares
Award · VAN NOSTRAND ROBERT L (Director) ·50,000 shares
Award · SCHEINBERG DAVID A (Director) ·50,000 shares
14 more
Award · WASMAN JANE ·50,000 shr
Award · CICIC DRAGAN ·300,000 shr
Buy · KALIN KATHERINE BACH ·63,400 shr ·$100,806
Buy · VAN NOSTRAND ROBERT L ·10,000 shr ·$14,800
Buy · WASMAN JANE ·20,000 shr ·$33,800
Buy · KALIN KATHERINE BACH ·20,000 shr ·$36,000
Award · STERGIOU ANGELOS M ·500,900 shr
Award · KALIN KATHERINE BACH ·12,500 shr
Award · VARIAN JOHN W ·12,500 shr
Award · VAN NOSTRAND ROBERT L ·12,500 shr
Award · SCHEINBERG DAVID A ·12,500 shr
Award · WASMAN JANE ·12,500 shr
Award · CICIC DRAGAN ·194,300 shr
Award · BURNS JOHN THOMAS ·194,300 shr